PharmaCyte Biotech Ownership | Who Owns PharmaCyte Biotech?

PharmaCyte Biotech Ownership Summary

PharmaCyte Biotech is owned by 10.50% institutional investors, 8.89% insiders, and 80.61% retail investors. K2 principal fund is the largest institutional shareholder, holding 3.81% of PMCB shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.53% of its assets in PharmaCyte Biotech shares.

PMCB Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	PharmaCyte Biotech	10.50%	8.89%	80.61%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
K2 principal fund	327.50K	3.81%	$641.91K
Vanguard group	192.39K	2.24%	$377.08K
Geode capital management	176.60K	2.05%	$346.17K
Equitec proprietary markets	82.73K	0.96%	$162.15K
Susquehanna group, llp	54.83K	0.64%	$107.47K
Renaissance	48.50K	0.56%	$95.06K
Ubs group	27.57K	0.32%	$54.05K
Dimensional fund advisors lp	25.60K	0.30%	$50.17K
Schonfeld strategic advisors	23.70K	0.28%	$46.45K
Northern trust	19.21K	0.22%	$37.65K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Equitec proprietary markets	82.73K	0.21%	$162.15K
K2 principal fund	327.50K	0.12%	$641.91K
Aspire private capital	800.00	0.00%	$1.57K
Schonfeld strategic advisors	23.70K	0.00%	$46.45K
Tower research capital llc (trc)	7.38K	0.00%	$14.47K
Renaissance	48.50K	0.00%	$95.06K
Planning capital management	100.00	0.00%	$196.00
Two sigma securities	-	-	-
Bfsg	5.00	-	$10.00
Bank of america corp /de/	152.00	-	$298.00

Top Buyers

Holder	Shares	% Assets	Change
Ubs group	27.57K	-	27.57K
Vanguard group	192.39K	-	17.79K
Susquehanna group, llp	54.83K	-	13.65K
Renaissance	48.50K	0.00%	4.70K
Tower research capital llc (trc)	7.38K	0.00%	4.16K

Top Sellers

Holder	Shares	% Assets	Change
Two sigma securities	-	-	-27.75K
Geode capital management	176.60K	-	-23.68K
Citadel advisors	-	-	-8.56K
Blackrock	13.35K	-	-7.76K
Advisor group	513.00	-	-1.25K

New Positions

Holder	Shares	% Assets	Change	Value
Planning capital management	100.00	0.00%	100.00	$196.00

Sold Out

Holder	Change
Private wealth management group	-42.00
Wells fargo & company/mn	-55.00
Redwood wealth management group	-69.00
Covestor	-226.00
Kelly financial services	-234.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	23	-8.00%	825,885	-19.96%	10	7.30%	5	-58.33%	9	28.57%
Jun 30, 2024	25	-16.67%	1,031,877	5.50%	11	9.28%	12	9.09%	7	-12.50%
Mar 31, 2024	30	-6.25%	978,076	-10.11%	11	7.37%	11	-21.43%	8	-11.11%
Dec 31, 2023	32	10.34%	1,088,077	-4.77%	12	15.10%	14	27.27%	9	12.50%
Sep 30, 2023	29	-3.33%	1,142,622	-5.81%	9	22.23%	11	22.22%	8	-38.46%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	117.47K	1.53%	-
Vanguard Institutional Extnd Mkt Idx Tr	74.92K	0.98%	-
Fidelity Total Market Index	55.70K	0.73%	-10.22K
Fidelity Extended Market Index	43.32K	0.56%	4.45K
Fidelity Nasdaq Composite Index	26.21K	0.34%	-
Spartan Total Market Index Pool E	19.64K	0.26%	161.00
Fidelity Series Total Market Index	16.36K	0.21%	-2.95K
NT Ext Equity Mkt Idx Fd - NL	14.43K	0.19%	-
NT Ext Equity Mkt Idx Fd - DC - NL - T2	11.63K	0.15%	36.00
Dimensional US Core Equity 2 ETF	11.51K	0.15%	-

Insider Transactions Trends

Date	Buy	Sell
2023 Q4	-	-
2022 Q4	-	-
2022 Q3	-	-
2022 Q1	-	-
2021 Q3	-	-

PMCB Ownership FAQ

Who Owns PharmaCyte Biotech?

PharmaCyte Biotech shareholders are primarily institutional investors at 10.50%, followed by 8.89% insiders and 80.61% retail investors. The average institutional ownership in PharmaCyte Biotech's industry, Biotech Stocks , is 47.04%, which PharmaCyte Biotech falls below.

Who owns the most shares of PharmaCyte Biotech?

PharmaCyte Biotech’s largest shareholders are K2 principal fund (327.5K shares, 3.81%), Vanguard group (192.39K shares, 2.24%), and Geode capital management (176.6K shares, 2.05%). Together, they hold 8.09% of PharmaCyte Biotech’s total shares outstanding.

Does Blackrock own PharmaCyte Biotech?

BlackRock is not among the top 10 institutional shareholders of PharmaCyte Biotech.

Who is PharmaCyte Biotech’s biggest shareholder by percentage of total assets invested?

Equitec proprietary markets is PharmaCyte Biotech’s biggest shareholder by percentage of total assets invested, with 0.21% of its assets in 82.73K PharmaCyte Biotech shares, valued at 162.14K$.

Who is the top mutual fund holder of PharmaCyte Biotech shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of PharmaCyte Biotech shares, with 1.53% of its total shares outstanding invested in 117.47K PharmaCyte Biotech shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools